Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Argos Therapeutics Provides Update on Clinical Research for Investigational Fully Personalized Immunotherapy for the Treatment of HIV

GlobeNewswire January 9, 2015

Theralase Summarizes its 2014 Scientific Achievements and 2015 Strategic Objectives

TheNewsWire January 9, 2015

Cipher Pharmaceuticals acquires assets of Melanovus Oncology Inc.

Canada NewsWire January 9, 2015

Incyte and Agenus Announce Global Alliance to Develop Novel Immuno-Oncology Antibodies

Business Wire January 9, 2015

AVEO Names Michael N. Needle, M.D., As Chief Medical Officer

Business Wire January 9, 2015

FoundationOne® Identifies High Frequency of Clinically Relevant Genomic Alterations (GA) Previously Missed by Conventional Genomic Tests, Enabling Successful Targeted Treatment in Patients with Non-Small Cell Lung Cancer

Business Wire January 9, 2015

Research and Markets: Global Regenerative Medicine Market 2015-2019 with Baxter International, Kinetic Concepts, Medtronic & Stryker Dominating

Business Wire January 9, 2015

DiaCarta, Inc Closes $8 Million Series A Round for Development and Commercialization of Precision Molecular Diagnostics

PR Newswire January 9, 2015

NantHealth and NantOmics to Present at the 33rd Annual J.P. Morgan Healthcare Conference

Business Wire January 9, 2015

Genclis selected to present its diagnostic technology Severidia(R) at the St. Gallen International Breast Cancer Conference

GlobeNewswire January 9, 2015

Genclis selected to present its diagnostic technology Severidia® at the St. Gallen International Breast Cancer Conference

Thomson Reuters ONE January 9, 2015

Cellular Dynamics to Present at 33rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 8, 2015

Technogym's Pioneering mywellness Cloud Continues to Innovate and Lead the Fitness Industry in Health and Wellness Tracking at CES 2015

Business Wire January 8, 2015

Kite Pharma Announces Addition of Scott N. Bernstein as Vice President of Intellectual Property Law

GlobeNewswire January 8, 2015

Study: Geologic patterns in rover pics suggest life on Mars

UPI January 8, 2015

AMP Releases "Molecular Diagnostic Perfect Storm" Paper Addressing the Convergence of Regulatory and Reimbursement Forces that Threaten Patient Care

Business Wire January 8, 2015

KaloBios Announces Retirement of David W. Pritchard, President and Chief Executive Officer

PR Newswire January 8, 2015

Journal of Cardiovascular Pharmacology Publishes Positive Nonclinical Results of Proteon Therapeutics' PRT-201 in Peripheral Artery Disease

GlobeNewswire January 8, 2015

The 7th Annual Biotech Showcase(TM) to Begin Next Week

PR Newswire January 8, 2015

Amgen To Present At The 33rd Annual J.P. Morgan Healthcare Conference

PR Newswire January 8, 2015